Effect of ginsenoside Rg1 on hematopoietic stem cells in treating aplastic anemia in mice via MAPK pathway

Figure 5 Ginsenoside Rg1 have the ability to inhibit inflammation of hematopoietic stem cells from aplastic anemia mice in vitro. A: The content of interleukin (IL)-10; B: The content of IL-6; C: The content of tumor necrosis factor (TNF)-α; D: The content of IL-1β; E: Western blot assay of IL-6, CCL2, and IL-1β in different group, the endogenous control used was GAPDH. ^bP < 0.01, compared to the normal group; ^cP < 0.05, ^dP < 0.01, compared to the aplastic anemia (AA) group.